Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Xenova, Lilly collaborate on new antithrombotics

Feb. 20, 1998

Lilly claims thrombin inhibitors

Feb. 19, 1998

New cell adhesion inhibitors from Shionogi

Feb. 19, 1998

Centocor to acquire rights to reteplase in U.S., Canada

Feb. 18, 1998

Tsetse thrombin inhibitor isolated, purified and characterized at Yale

Feb. 18, 1998

Canadian market introduction for Fraxiparine announced

Feb. 10, 1998

Lovenox approved for at-home use in U.S.

Feb. 9, 1998

Anticoagulant apoB-100 fragment discovered at Royal Free Hospital

Feb. 6, 1998

TIMI 12 trial results published

Feb. 4, 1998

Lactoferrin use in heparin neutralization described

Feb. 3, 1998

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...